Your email has been successfully added to our mailing list.

×
0.0211990278152848 0.0211990278152848 0.0211990278152848 0.0234944639481501 0.0234944639481501 0.0261949770456386 0.0261949770456386 0.0219416689170942
Stock impact report

Is Biogen Too Cheap to Ignore? [The Motley Fool]

EISAI CO S/ADR (ESALY) 
NASDAQ:AMEX Investor Relations: eisai.com/ir/index.html
Company Research Source: The Motley Fool
Biogen ( NASDAQ:BIIB Is Biogen a good value play, or should investors look elsewhere? Why Biogen's stock has been so volatile Biogen's two massive price movements this year -- in March and in October -- had the exact same cause, namely the company's development of aducanumab to treat Alzheimer's disease (AD). The news in March was that the company was discontinuing its efforts to send aducanumab to the U.S. Food and Drug Administration's (FDA) desk for approval. The reason behind that disappointing bit of news was the fact that aducanumab failed to prove its efficacy during a pivotal phase clinical study. Image source: Getty Images. More precisely, monthly doses of aducanumab failed to slow "cognitive and functional impairment" in AD patients. However, the company brought aducanumab back from the trash bin in There is, at this point, no guarantee that aducanumab will clear the FDA hurdle, but if it does, the AD medicine could be a major growth driver for Biogen. More products on the Show less Read more
Impact Snapshot
Event Time:
ESALY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ESALY alerts
Opt-in for
ESALY alerts

from News Quantified
Opt-in for
ESALY alerts

from News Quantified